Comprehensive Heme Profiling

This panel is designed to support the diagnosis, prognosis, and treatment planning of a wide range of hematologic malignancies. By analyzing genetic mutations across both myeloid and lymphoid lineages, it offers a holistic approach to understanding hematologic disorders. This comprehensive genetic profiling enables personalized treatment strategies, enhances the accuracy of risk assessment, and supports effective therapeutic interventions, thereby improving overall patient outcomes.